Evrofarma SA (EVROF.AT)
EUR 1.63
(0.93%)
EUR 1.63
(0.93%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.05 Million EUR | 26.51% |
| 2022 | 5.58 Million EUR | 45.35% |
| 2021 | 3.83 Million EUR | -18.91% |
| 2020 | 4.73 Million EUR | -20.77% |
| 2019 | 5.97 Million EUR | -0.96% |
| 2018 | 6.03 Million EUR | 13.94% |
| 2017 | 5.29 Million EUR | 3.48% |
| 2016 | 5.11 Million EUR | -22.83% |
| 2015 | 6.63 Million EUR | 8.99% |
| 2014 | 6.08 Million EUR | 46.32% |
| 2013 | 4.15 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.68 Million EUR | 0.0% |
| 2023 Q3 | 1.33 Million EUR | -39.42% |
| 2023 FY | 3.67 Million EUR | -34.07% |
| 2023 Q1 | 2.19 Million EUR | 32.25% |
| 2023 Q2 | 2.19 Million EUR | 0.0% |
| 2023 Q4 | 1.33 Million EUR | 0.0% |
| 2022 Q4 | 1.66 Million EUR | 0.0% |
| 2022 Q3 | 1.66 Million EUR | 34.52% |
| 2022 Q1 | 1.23 Million EUR | 199.15% |
| 2022 FY | 5.58 Million EUR | 45.35% |
| 2022 Q2 | 1.23 Million EUR | 0.0% |
| 2021 FY | 3.83 Million EUR | -18.91% |
| 2021 Q1 | 1.5 Million EUR | -39.35% |
| 2021 Q4 | 413 Thousand EUR | 0.0% |
| 2021 Q2 | 3.05 Million EUR | 102.59% |
| 2021 Q3 | 413 Thousand EUR | -86.47% |
| 2020 Q4 | 2.48 Million EUR | 130.86% |
| 2020 FY | 4.73 Million EUR | -20.77% |
| 2020 Q2 | 2.8 Million EUR | 97.95% |
| 2020 Q1 | 1.41 Million EUR | -51.65% |
| 2020 Q3 | 1.07 Million EUR | -61.64% |
| 2019 Q2 | 3.54 Million EUR | 100.0% |
| 2019 FY | 5.97 Million EUR | -0.96% |
| 2019 Q4 | 2.93 Million EUR | 133.17% |
| 2019 Q3 | 1.25 Million EUR | -64.5% |
| 2019 Q1 | 1.77 Million EUR | 36.3% |
| 2018 Q3 | 1.29 Million EUR | -15.51% |
| 2018 FY | 6.03 Million EUR | 13.94% |
| 2018 Q4 | 1.29 Million EUR | 0.0% |
| 2018 Q2 | 1.53 Million EUR | 0.0% |
| 2018 Q1 | 1.53 Million EUR | 22.95% |
| 2017 Q2 | 1.28 Million EUR | 0.0% |
| 2017 FY | 5.29 Million EUR | 3.48% |
| 2017 Q3 | 1.25 Million EUR | -2.99% |
| 2017 Q4 | 1.25 Million EUR | 0.0% |
| 2017 Q1 | 1.28 Million EUR | 3.87% |
| 2016 FY | 5.11 Million EUR | -22.83% |
| 2016 Q2 | 1.45 Million EUR | 0.0% |
| 2016 Q1 | 1.45 Million EUR | -1.83% |
| 2016 Q4 | 1.24 Million EUR | 0.0% |
| 2016 Q3 | 1.24 Million EUR | -14.47% |
| 2015 Q4 | 1.47 Million EUR | 1.09% |
| 2015 FY | 6.63 Million EUR | 8.99% |
| 2015 Q3 | 1.46 Million EUR | -19.63% |
| 2015 Q2 | 1.81 Million EUR | 14.19% |
| 2015 Q1 | 1.59 Million EUR | -7.33% |
| 2014 FY | 6.08 Million EUR | 46.32% |
| 2014 Q2 | 1.44 Million EUR | 42.97% |
| 2014 Q3 | 1.91 Million EUR | 32.34% |
| 2014 Q4 | 1.71 Million EUR | -10.05% |
| 2014 Q1 | 1.01 Million EUR | 10.38% |
| 2013 Q2 | 1.07 Million EUR | 22.83% |
| 2013 Q3 | 1.29 Million EUR | 19.98% |
| 2013 Q1 | 876 Thousand EUR | 0.0% |
| 2013 FY | 4.15 Million EUR | 0.0% |
| 2013 Q4 | 915 Thousand EUR | -29.12% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 12.76 Million EUR | 44.686% |
| Kri-Kri Milk Industry S.A. | 72.46 Million EUR | 90.259% |
| Loulis Food Ingredients S.A. | 28.02 Million EUR | 74.813% |